CD19‐targeting chimeric antigen receptor T‐cell therapy is safe and effective for intra‐cardiac B cell non‐Hodgkin lymphoma
- DOI
- 10.1002/jha2.1020
- Published
- 2024-10-17
- Container
- eJHaem
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/jha2.1020,
title = {CD19‐targeting chimeric antigen receptor T‐cell therapy is safe and effective for intra‐cardiac B cell non‐Hodgkin lymphoma},
author = {Daniel H. Chen and Maeve O'Reilly and Kathleen P. Cheok and Ryan Low and Rajesh Puranik and Samuel Clark and John Malcolm Walker and Charlotte Manisty and Arjun K. Ghosh and Claire Roddie},
year = {2024},
journal = {eJHaem},
doi = {10.1002/jha2.1020},
url = {https://doi.org/10.1002/jha2.1020}
}RIS
TY - JOUR TI - CD19‐targeting chimeric antigen receptor T‐cell therapy is safe and effective for intra‐cardiac B cell non‐Hodgkin lymphoma AU - Daniel H. Chen AU - Maeve O'Reilly AU - Kathleen P. Cheok AU - Ryan Low AU - Rajesh Puranik AU - Samuel Clark AU - John Malcolm Walker AU - Charlotte Manisty AU - Arjun K. Ghosh AU - Claire Roddie PY - 2024 JO - eJHaem DO - 10.1002/jha2.1020 UR - https://doi.org/10.1002/jha2.1020 ER -
APA
Chen, D. H., O'Reilly, M., Cheok, K. P., Low, R., Puranik, R., Clark, S., Walker, J. M., Manisty, C., Ghosh, A. K., & Roddie, C. (2024). CD19‐targeting chimeric antigen receptor T‐cell therapy is safe and effective for intra‐cardiac B cell non‐Hodgkin lymphoma. eJHaem. https://doi.org/10.1002/jha2.1020
Source records
- crossref · retrieved 2026-09-26T03:15:39.139Z